PATRICIA
PALAU SAMPIO
TITULAR DE UNIVERSIDAD
Hospital Universitario Virgen de la Victoria
Málaga, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (5)
2024
-
Obesity and cardiovascular and renal disease. Consensus document of the Preventive Cardiology, Clinical Cardiology, and Heart Failure Associations of the Spanish Society of Cardiology
REC: CardioClinics, Vol. 59, Núm. 3, pp. 212-224
2023
-
Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction
Scientific Reports, Vol. 13, Núm. 1
-
Early glomerular filtration rate decline is associated with hemoglobin rise following dapagliflozin initiation in heart failure with reduced ejection fraction
Revista Espanola de Cardiologia, Vol. 76, Núm. 10, pp. 783-792
-
Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life and Natriuretic Peptides After Initiation of Dapagliflozin in Heart Failure With Reduced Ejection Fraction
Journal of Cardiac Failure, Vol. 29, Núm. 5, pp. 849-854
2022
-
Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2): a randomized clinical trial
European Journal of Heart Failure, Vol. 24, Núm. 10, pp. 1816-1826